Clinical Trials
5 trialsNCT07020533 2026-03-27
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
City of Hope Medical Center
Phase 1 Recruiting
NCT06449586 2025-12-15
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT
Ruijin Hospital
Phase 3 Active not recruiting
NCT06920251 2025-12-03
OPTIMUS-EL
Seoul National University Hospital
Phase 2 Recruiting
NCT04060277 2025-11-14
Triplex Vaccine in Preventing CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
City of Hope Medical Center
Phase 2 Active not recruiting
NCT04017962 2025-08-11
A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Completed